World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT01965691
Date of registration: 16/10/2013
Prospective Registration: No
Primary sponsor: University of British Columbia
Public title: Protein Requirements in Children With Phenylketonuria (PKU)
Scientific title: Application of Stable Isotopes to Determine Protein Requirements in Children With Phenylketonuria (PKU)
Date of first enrolment: October 2013
Target sample size: 4
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT01965691
Study type:  Interventional
Study design:  Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Supportive Care. Masking: None (Open Label).  
Phase:  N/A
Countries of recruitment
Canada
Contacts
Name:     Keiko Ueda, MPH, RD
Address: 
Telephone:
Email:
Affiliation:  Provincial Health Services Authority
Name:     Rajavel Elango, PhD
Address: 
Telephone:
Email:
Affiliation:  Child and Family Research Institute, University of British Columbia
Name:     Sylvia Stockler-Ipsiroglu, MD
Address: 
Telephone:
Email:
Affiliation:  University of British Columbia
Key inclusion & exclusion criteria

Inclusion Criteria:

- Children (5-18y) who are diagnosed with Phenylketonuria (PKU), and clinically stable
with no acute illness

Exclusion Criteria:

- Children less than 5y of age and who are diagnosed with PKU, as it may be difficult to
take breath samples and perform indirect calorimetry in very young children.

- Children diagnosed with PKU, but are currently ill, with a fever, cold, vomiting or
diarrhea.



Age minimum: 5 Years
Age maximum: 18 Years
Gender: All
Health Condition(s) or Problem(s) studied
Phenylketonuria
Intervention(s)
Dietary Supplement: Protein intake
Primary Outcome(s)
13 Co2 production [Time Frame: 8 hours (1 study day)]
Secondary Outcome(s)
Secondary ID(s)
H13-00220
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Saudi Arabian Cultural Bureau, Ottawa
Rare Disease Foundation, Vancouver, Canada
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history